An Analysis of Amicus Therapeutics Inc (FOLD)’s Potential Price Growth
In a filing, Amicus Therapeutics Inc revealed its President and CEO Campbell Bradley L unloaded Company’s shares for reported $87496.0 on Apr 01 ’24. In the deal valued at $11.67 per share,7,500 shares were sold. As a result of this transaction, Campbell Bradley L now holds 886,654 shares worth roughly $9.45 million. Then, MCGLYNN MARGARET […]
FOLD’s short interest reaches 32.4 million shares on Mar 15, 2024
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics Inc shares valued at $87,496 were sold by Campbell Bradley L on Apr 01 ’24. At $11.67 per share, Campbell Bradley L sold 7,500 shares. The insider’s holdings dropped to 886,654 shares worth approximately $9.95 […]
Amicus Therapeutics Inc (FOLD) Becoming More Attractive for Investors
Amicus Therapeutics Inc’s recently made public that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $87496.0 on Apr 01 ’24. In the deal valued at $11.67 per share,7,500 shares were sold. As a result of this transaction, Campbell Bradley L now holds 886,654 shares worth roughly $10.29 million. Then, MCGLYNN MARGARET […]
Amicus Therapeutics Inc [FOLD] Records 200-Day SMA of $12.33
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Amicus Therapeutics Inc shares valued at $87,496 were sold by Campbell Bradley L on Apr 01 ’24. At $11.67 per share, Campbell Bradley L sold 7,500 shares. The insider’s holdings dropped to 886,654 shares […]
Amicus Therapeutics Inc [FOLD] Investment Guide: What You Need to Know
Amicus Therapeutics Inc’s filing revealed that its Director MCGLYNN MARGARET G unloaded Company’s shares for reported $0.1 million on Mar 05 ’24. In the deal valued at $13.40 per share,7,500 shares were sold. As a result of this transaction, MCGLYNN MARGARET G now holds 59,289 shares worth roughly $0.7 million. Then, MCGLYNN MARGARET G sold […]
Morgan Stanley upgrades Amicus Therapeutics Inc (FOLD) stock to an Overweight
Amicus Therapeutics Inc’s filing revealed that its Director MCGLYNN MARGARET G unloaded Company’s shares for reported $0.1 million on Mar 05 ’24. In the deal valued at $13.40 per share,7,500 shares were sold. As a result of this transaction, MCGLYNN MARGARET G now holds 59,289 shares worth roughly $0.68 million. Then, MCGLYNN MARGARET G sold […]
